share_log

Chemomab Therapeutics Q4 EPS $(0.26) Up From $(0.72) YoY

Chemomab Therapeutics Q4 EPS $(0.26) Up From $(0.72) YoY

Chemomab Therapeutics第四季度每股收益美元(0.26美元)高於同比增長0.72美元
Moomoo 24/7 ·  03/07 07:06

Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.26) per share. This is a 63.89 percent increase over losses of $(0.72) per share from the same period last year.

Chemomab Therapeutics(納斯達克股票代碼:CMMB)報告稱,季度每股虧損爲0.26美元。這比去年同期每股虧損0.72美元(0.72美元)增長了63.89%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論